Jean M. Franchi - Net Worth and Insider Trading
Jean M. Franchi Net Worth
The estimated net worth of Jean M. Franchi is at least $1 Million dollars as of 2024-07-16. Jean M. Franchi is the CFO of Replimune Group Inc and owns about 128,748 shares of Replimune Group Inc (REPL) stock worth over $1 Million. Details can be seen in Jean M. Franchi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jean M. Franchi has not made any transactions after 2023-05-16 and currently still holds the listed stock(s).
Transaction Summary of Jean M. Franchi
Jean M. Franchi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jean M. Franchi owns 4 companies in total, including Replimune Group Inc (REPL) , Merrimack Pharmaceuticals Inc (MACK) , and Dimension Therapeutics Inc (DMTX) among others .
Click here to see the complete history of Jean M. Franchi’s form 4 insider trades.
Insider Ownership Summary of Jean M. Franchi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REPL | Replimune Group Inc | 2023-05-16 | Chief Financial Officer |
| MACK | Merrimack Pharmaceuticals Inc | 2017-08-21 | Chief Financial Officer |
| DMTX | Dimension Therapeutics Inc | 2017-02-01 | Chief Financial Officer |
 | | 2021-06-29 | director |
Jean M. Franchi Latest Holdings Summary
Jean M. Franchi currently owns a total of 1 stock. Jean M. Franchi owns 128,748 shares of Replimune Group Inc (REPL) as of May 16, 2023, with a value of $1 Million.
Latest Holdings of Jean M. Franchi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REPL | Replimune Group Inc | 2023-05-16 | 128,748 | 10.75 | 1,384,041 |
Holding Weightings of Jean M. Franchi
Jean M. Franchi Form 4 Trading Tracker
According to the SEC Form 4 filings, Jean M. Franchi has made a total of 4 transactions in Replimune Group Inc (REPL) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Replimune Group Inc is the sale of 11,351 shares on May 16, 2023, which brought Jean M. Franchi around $204,886.
Insider Trading History of Jean M. Franchi
- 1
Jean M. Franchi Trading Performance
Jean M. Franchi Ownership Network
Jean M. Franchi Owned Company Details
What does Replimune Group Inc do?
Who are the key executives at Replimune Group Inc?
Jean M. Franchi is the Chief Financial Officer of Replimune Group Inc. Other key executives at Replimune Group Inc include Chief Medical Officer Konstantinos Xynos , Chief Commercial Officer Christopher Sarchi , and Chief Accounting Officer Andrew Schwendenman .
Replimune Group Inc (REPL) Insider Trades Summary
Over the past 18 months, Jean M. Franchi made 1 insider transaction in Replimune Group Inc (REPL) with a net sale of 11,351. Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 51,624 shares made by Pamela Esposito , a net sale of 30,332 shares made by Konstantinos Xynos , and a net sale of 41,467 shares made by Sushil Patel .
In summary, during the past 3 months, insiders sold 113,965 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 113,965 shares. During the past 18 months, 273,157 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 273,157 shares.
Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Replimune Group Inc Insider Transactions
Jean M. Franchi Mailing Address
Above is the net worth, insider trading, and ownership report for Jean M. Franchi. You might contact Jean M. Franchi via mailing address: C/o Dimension Therapeutics, Inc., 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
